Therapeutic TRAIL fusion protein and preparation and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403892
APP PUB NO 20140206843A1
SERIAL NO

14165555

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to the biotechnology area, and provides a kind of TRAIL chimeric protein, DNA sequence encoding this chimeric protein, vectors comprising this DNA, host cells or transgenic animals that contain one of the vectors, and preparation methods for the said chimeric protein and its applications. The said TRAIL fusion protein from the N to C terminal comprises human leucine zipper sequence, human TRAIL protein, human TRAIL extracellular domain or a fragment thereof. The chimeric protein has significantly enhanced stability, prolonged half-life in animals, increased efficacy and thus has broad application future.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAGELLAN PHARMA CO LTDROOM 706 DINGYE BAITAI BUILDING C NO 10 XINGHUO ROAD HI-TECH ZONE PUKOU DISTRICT NANJING

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jiang, Jing Yantai, CN 775 9041
Zhou, Bing Yantai, CN 202 2194
Zhou, Yu Yantai, CN 454 2834

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00